MBX Biosciences MBX 深 沪
已收盘 10-24 16:00:00 美东时间
17.00
+0.870
+5.39%
华盛通- 最 高17.03
- 今 开16.20
- 成交量 65.93万股
- 最 低 15.96
- 昨 收 16.13
- 总市值 5.71亿
- 52周最高 27.50
- 市盈率 静 --
- 换手率 1.96%
- 52周最低 4.8069
- 委 比 -96.77%
- 总股本 3359.39万
- 历史最高 27.50
- 量 比 0.78
- 振 幅 6.63%
- 历史最低 4.8069
- 每 手 1
- 风险率 4.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MBX Biosciences to Participate in November Investor Conferences
<p>MBX Biosciences, a biopharmaceutical company specializing in precision peptide therapies for endocrine and metabolic disorders, announced that its CEO, Kent Hawryluk, and CMO, Sam Azoulay, will participate in four investor conferences in November 2025. The events include the Guggenheim Healthcare Innovation Conference in Boston, the Stifel Healthcare Conference in New York, the Jefferies Global Healthcare Conference in London, and a virtual su...
10-20 12:00
Tarrina Resources Limited Announces Name and ASX Code Change
My Foodie Box Limited ( ($AU:MBX) ) has shared an announcement. Tarrina Resourc...
10-16 15:52
美股大行评级 | 贝莱德、花旗、摩根大通、富国银行均获上调目标价！汇丰上调超微公司目标价升至310美元
今日重点评级关注：Roth Capital：维持Cingulate"买入"评级，目标价从10美元升至17美元；JMP证券：维持BioCryst Pharma"跑赢大市"评级，目标价从17美元升至27美元
10-16 10:43
Truist Securities Initiates Coverage On MBX Biosciences with Buy Rating, Announces Price Target of $50
Truist Securities analyst Srikripa Devarakonda initiates coverage on MBX Biosciences (NASDAQ:MBX) with a Buy rating and announces Price Target of $50.
10-15 19:37
MBX Biosciences, Inc. (MBX) Gets a Buy from Guggenheim
In a report released today, Seamus Fernandez from Guggenheim reiterated a Buy r...
10-06 20:15
MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum
MBX Biosciences, Inc. announced that its CEO, Kent Hawryluk, and Chief Medical Officer, Sam Azoulay, MD, will participate in a fireside chat at the Stifel 2025 Virtual Cardiometabolic Forum on September 30, 2025, at 10:00 a.m. ET. The live webcast and replay can be accessed via the company's website. MBX Biosciences focuses on developing peptide therapies for endocrine and metabolic disorders.
09-29 12:00
MBX Biosciences将公开发行股票筹集近2亿美元
MBX Biosciences（MBX）周四早盘重挫11.1%，将其扩大规模的公开发行价格定为每股18.00美元，旨在筹集约1.999亿美元。此次发行最初计...
09-25 22:55
美股大行评级 | 217美元！花旗上调阿里巴巴目标价；多家机构集体上调麦克森、美光科技等目标价
今日重点评级关注：Ascendiant Capital：维持Maison Solutions"买入"评级，目标价从4美元升至4.25美元；瑞穗：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至56美元
09-25 09:52
美股大行评级 | 升至450美元，瑞穗上调特斯拉目标价；富国银行上调CoreWeave至"超配"，目标价升至170美元
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从44美元升至84美元；Oppenheimer：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至80美元
09-24 10:23
美股牛股 | 减肥药公司Metsera暴涨60%！获辉瑞溢价收购；Anywhere与Compass宣布合并
减肥药公司Metsera暴涨60%！获辉瑞溢价收购；巨型地产平台诞生，Anywhere单日大涨45%，宣布与Compass合并>>
09-23 16:54
